Literature DB >> 25025387

Orbital Epithelioid Sarcoma: A Case Report.

Lama L Jurdy1, Leo E Blank, Johannes Bras, Peerooz Saeed.   

Abstract

Epithelioid sarcoma is a rare but often aggressive malignancy of soft tissue that usually occurs in young adults as a superficial lesion in the distal upper limbs. To date, there are only 4 case reports of epithelioid sarcoma primarily occurring in the orbit. Two of these patients were treated with primary exenteration only one of whom was alive 3 years after diagnosis. Radical surgical excision is thus the first treatment of choice for primary orbital epithelioid sarcoma. The authors present a patient with primary orbital epithelioid sarcoma who refused exenteration. Surgical debulking followed by local brachytherapy was performed. The patient remains tumor free 5 years after diagnosis. The literature remains limited regarding treatment options for primary orbital epithelioid sarcoma. However, based on reported cases and this case, the authors conclude that surgical excision combined with local iridium radiation therapy is an acceptable treatment when treating primary orbital epithelioid sarcoma.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 25025387     DOI: 10.1097/IOP.0000000000000227

Source DB:  PubMed          Journal:  Ophthalmic Plast Reconstr Surg        ISSN: 0740-9303            Impact factor:   1.746


  2 in total

1.  Epithelioid sarcoma arising from the temporal space: A case report.

Authors:  Yong Seek Kim; Hyo Sung Kwak; Gyung Ho Chung; Yo Na Kim; Seungbae Hwang
Journal:  Medicine (Baltimore)       Date:  2018-09       Impact factor: 1.817

Review 2.  New Medical Device and Therapeutic Approvals in Otolaryngology: State of the Art Review 2020.

Authors:  Michael J Brenner; Jared A Shenson; Austin S Rose; Tulio A Valdez; Masayoshi Takashima; Omar G Ahmed; Philip A Weissbrod; Robert S Hong; Hamid Djalilian; Jeffrey S Wolf; Robert J Morrison; Peter L Santa Maria; Isaac D Erbele
Journal:  OTO Open       Date:  2021-11-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.